Double Bond Pharmaceutical receives patent in the United States for the BeloGal® platform TUE, JUL 31, 2018 08:00 CET Double Bond Pharmaceuticals patent application for organ-specific administration of hydrophilic cancer drug to the liver which forms the basis for the BeloGal® technology platform has been [...]
The sterilization process for Temozolomide is secured MON, JUL 23, 2018 08:00 CET Double Bond Pharmaceutical reports that technology transfer of the sterilization process for Temozolomide in SI-053 has been conducted with satisfactory results. The process has been carried out by a company specializing in [...]
Double Bond Pharmaceutical has been granted Eurostars funding for development a new product for treatment of pneumonia MON, JUL 16, 2018 08:00 CET A consortium consisted of Double Bond Pharmaceutical together with Karolinska Institute and international partnering SMEs from France has been granted a Eurostars [...]
Sterilization process for the excipient in SI-053 secured MON, JUL 02, 2018 08:00 CET Double Bond Pharmaceutical reports that transfer of the sterilization process for the excipient in SI-053 has been completed with satisfactory results. The process has been performed by a contract sterilization company [...]
Double Bond Pharma signs agreement for distribution of Helixor products TUE, MAY 29, 2018 08:00 CET Double Bond Pharmaceutical (DBP) and Helixor Heilmittel GmbH have today signed an agreement for distribution of Helixor products in Sweden. The distribution will be held through Drugsson AB. Helixor [...]
Double Bond aims at adaptive design for SI-053 Phase I FRI, MAY 04, 2018 10:19 CET Double Bond Pharmaceutical (DBP) has signed a service contract with Cytel Inc, a leading provider of clinical research services and software, to develop an adaptive model-based study design for [...]
Double Bond Pharma signs logistics agreement with Tamro THU, APR 26, 2018 10:10 CET Today, Double Bond Pharmaceutical has signed an agreement with the wholesaler Tamro for distribution and storage of its product Pileseptin in Sweden, Norway and Denmark. Tamro is Sweden’s only independent pharmaceutical [...]
Double Bond Pharma signs agreement for distribution of Pharysol THU, APR 12, 2018 09:10 CET Double Bond Pharmaceutical (DBP) and Vitro-Bio have today signed an agreement for distribution of Pharysol in Sweden, Norway and Denmark. The distribution will be held through Drugsson AB. "In line [...]
